News & Articles

AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics

Researchers aim to tackle the issue of plastic waste by enhancing pre-existing PETase – a known digestive enzyme for plastic materials

The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics

The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers

Metafora biosystems receives exceptional reimbursement for the new METAglut1 test to help diagnose De Vivo disease

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

MMI launch their latest solution at the AACR meeting in Chicago: CellScan

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate